Anika Therapeutics, Inc. (ANIK) Tops Q1 Revenue Tops Views
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.20 -1.53%
Revenue Growth %: +3.5%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +3.5%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.97, $0.72 better than the analyst estimate of $0.25. Revenue for the quarter came in at $34 million versus the consensus estimate of $16.03 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- MP Materials seen largely insulated after China export-control move
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
